Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burdick

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
The Annals of Thoracic Surgery|August 2, 2011
Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarkerDamien J LaPar, Marie D Burdick, Abbas Emaminia, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 1, 1990
1,4-Dihydronaphthoquinones as water-soluble inhibitors of 5-lipoxygenaseR G Schaub, A Yamashita, M K Bach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1994
Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injuryR E Smith, R M Strieter, S H Phan, et al.
The American Journal of Pathology|October 9, 2002
The role of MIG/CXCL9 in cardiac allograft vasculopathyJames J Yun, Michael P Fischbein, David Whiting, et al.
The EMBO Journal|July 21, 2007
Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient miceSabine Müller-Brüsselbach, Martin Kömhoff, Markus Rieck, et al.
International Journal of Cancer|May 12, 2009
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancerYoichi Matsuo, Massimo Raimondo, Timothy A Woodward, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejectionJohn A Belperio, Michael P Keane, Marie D Burdick, et al.
Journal of Vascular Surgery|November 5, 1999
Neovascularization during venous thrombosis organization: a preliminary studyT W Wakefield, M J Linn, P K Henke, et al.
Blood|October 29, 2010
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3Sofie Struyf, Laura Salogni, Marie D Burdick, et al.
The Journal of Clinical Investigation|August 6, 1998
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancerD A Arenberg, M P Keane, B DiGiovine, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
The Annals of Thoracic Surgery|August 2, 2011
Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarkerDamien J LaPar, Marie D Burdick, Abbas Emaminia, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 1, 1990
1,4-Dihydronaphthoquinones as water-soluble inhibitors of 5-lipoxygenaseR G Schaub, A Yamashita, M K Bach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1994
Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injuryR E Smith, R M Strieter, S H Phan, et al.
The American Journal of Pathology|October 9, 2002
The role of MIG/CXCL9 in cardiac allograft vasculopathyJames J Yun, Michael P Fischbein, David Whiting, et al.
The EMBO Journal|July 21, 2007
Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient miceSabine Müller-Brüsselbach, Martin Kömhoff, Markus Rieck, et al.
International Journal of Cancer|May 12, 2009
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancerYoichi Matsuo, Massimo Raimondo, Timothy A Woodward, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejectionJohn A Belperio, Michael P Keane, Marie D Burdick, et al.
Journal of Vascular Surgery|November 5, 1999
Neovascularization during venous thrombosis organization: a preliminary studyT W Wakefield, M J Linn, P K Henke, et al.
Blood|October 29, 2010
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3Sofie Struyf, Laura Salogni, Marie D Burdick, et al.
The Journal of Clinical Investigation|August 6, 1998
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancerD A Arenberg, M P Keane, B DiGiovine, et al.
Pageof 27